| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5624003 | Alzheimer's & Dementia | 2015 | 9 Pages |
Abstract
This study strengthens the potential of neurogranin as an AD CSF biomarker, which now needs validation in larger studies. As tools, straightforward immunoassays can be used, as demonstrated by the described ELISA.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Ann De Vos, Dirk Jacobs, Hanne Struyfs, Erik Fransen, Kerstin Andersson, Erik Portelius, Ulf Andreasson, Didier De Surgeloose, Daniëlle Hernalsteen, Kristel Sleegers, Caroline Robberecht, Christine Van Broeckhoven, Henrik Zetterberg, Kaj Blennow,